BRIEF-Coherus Biosciences announces positive topline Phase III results for CHS-1420

* Coherus Biosciences announces positive topline phase three results for chs-1420 (humira biosimilar candidate) in patients with psoriasis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.